Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1945]

Reprogramming the cancer microenvironment with vaccine-based therapy

Prof Lei Zheng - John Hopkins Institute Baltimore, USA

Reprogramming the cancer microenvironment with vaccine-based therapy ( Prof Lei Zheng - John Hopkins Institute Baltimore, USA )

T cells expressing two additional receptors (TETARs) for the use in a multiple...

Dr Gerold Schuler - Universitätsklinikum, Erlangen, Germany

T cells expressing two additional receptors (TETARs) for the use in a multiple- hit immunotherapy ( Dr Gerold Schuler - Universitätsklinikum, Erlangen, Germany )

Biomarkers in t-cell therapy trials

Dr Jérôme Galon - Laboratory of Integrative Cancer Immunology, Paris, France

Biomarkers in t-cell therapy trials ( Dr Jérôme Galon - Laboratory of Integrative Cancer Immunology, Paris, France )

Immunotherapy and personalised medicine in review

Prof Paul Sondel - University of Wisconsin, Madison, USA

Immunotherapy and personalised medicine in review ( Prof Paul Sondel - University of Wisconsin, Madison, USA )

Rationale for combining immunotherapy with chemotherapy

Prof Angus Dalgleish - St. Georges University, London UK

Rationale for combining immunotherapy with chemotherapy ( Prof Angus Dalgleish - St. Georges University, London UK )

Targeting tumour vasculature by DNA vaccines

Dr Andrea Facciabene - University of Pennsylvania, Philadelphia, USA

Targeting tumour vasculature by DNA vaccines ( Dr Andrea Facciabene - University of Pennsylvania, Philadelphia, USA )

Editor's Choice for March 2016

Prof Gordon McVie - ecancer Editor

Editor's Choice for March 2016 ( Prof Gordon McVie - ecancer Editor )

Molecular drug imaging to guide brain cancer therapy

Dr Dannis Van Vuurden - VU University Medical Center, Amsterdam, The Netherlands

Molecular drug imaging to guide brain cancer therapy ( Dr Dannis Van Vuurden - VU University Medical Center, Amsterdam, The Netherlands )

Interstitial drug delivery to brain tumours

Dr Henry Brem - Johns Hopkins University, Baltimore, USA

Interstitial drug delivery to brain tumours ( Dr Henry Brem - Johns Hopkins University, Baltimore, USA )

Editor's choice for January 2016

Prof Gordon McVie - ecancer Editor

Editor's choice for January 2016 ( Prof Gordon McVie - ecancer Editor )

Advanced prostate cancer overview: Expert discussion

Dr Heather Payne, Prof Romano Danesi, Prof Luis da Costa, Prof Peter Mulders

Advanced prostate cancer overview: Expert discussion ( Dr Heather Payne, Prof Romano Danesi, Prof Luis da Costa, Prof Peter Mulders )

Entinostat and high-dose Interleukin 2 in renal cell carcinoma patients

Prof Roberto Pili - Indiana University, Indianapolis, USA

Entinostat and high-dose Interleukin 2 in renal cell carcinoma patients ( Prof Roberto Pili - Indiana University, Indianapolis, USA )

More from ecancer